Journal article
Osteoporosis risk screening for women in a community pharmacy
Journal of the American Pharmacists Association, Vol.47(4), pp.521-U121
07/01/2007
DOI: 10.1331/JAPhA.2007.05107
PMID: 17616501
Abstract
Objectives: To describe the development, implementation, and financial aspects of a sustainable osteoporosis screening service in a community pharmacy and report osteoporosis risk factors for women screened during the 48 months in which the screening service was in operation.
Setting: An independent community pharmacy (Main at Locust Pharmacy Clinic) in Davenport, Iowa, beginning in 1999.
Practice description: The osteoporosis screening service was provided by a staff pharmacist, a pharmacy resident, or a combination of a pharmacist and a resident. The service included use of the Hologic Sahara Bone Sonometer at the heel and education of the patient. Patient education consisted of a discussion of screening results, an overview of osteoporosis, and recommendations to address risk factors.
Practice innovation: For patients who received osteoporosis screening, an overall cumulative risk score and a cumulative modifiable risk score were calculated. Patients were identified as having high (T-score <=-1), moderate (-1 < T-score < 0), or low (T-score >= 0) risk. An analysis was performed to determine the net financial gain or loss of osteoporosis screening.
Intervention: Osteoporosis screening service.
Main outcome measures: T-score, overall cumulative risk score, cumulative modifiable risk score, and net financial gain of service.
Results: A total of 444 women received the osteoporosis screening service during 48 months. More than 90% of the women had an overall cumulative risk score of at least 3, and 83.3% had at least one modifiable risk factor. According to the bone density tests, about 58% of the women were at high risk for osteoporosis and 25.7% were at moderate risk. The service had a net gain if provided by a pharmacist ($4,823.72), a resident ($8,153.72), or a combination of a pharmacist and a resident ($6,488.72).
Conclusion: This pharmacy-based osteoporosis screening service effectively identified patients at risk for osteoporosis and was sustainable for 48 months. Other community pharmacies are encouraged to offer similar services.
Details
- Title: Subtitle
- Osteoporosis risk screening for women in a community pharmacy
- Creators
- Yifei Liu - University of IowaJustin C. Nevins - University of IowaKara M. CarruthersWilliam R. Doucette - University of IowaRandal P. McDonough - Towncrest Pharmacy, Iowa City.Xiaoyun Pan - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Journal of the American Pharmacists Association, Vol.47(4), pp.521-U121
- Publisher
- Elsevier
- DOI
- 10.1331/JAPhA.2007.05107
- PMID
- 17616501
- ISSN
- 1544-3191
- eISSN
- 1544-3450
- Number of pages
- 13
- Language
- English
- Date published
- 07/01/2007
- Academic Unit
- Pharmacy Practice and Science
- Record Identifier
- 9984366038802771
Metrics
4 Record Views